Ellen Kurek

Despite good responses, patients dropped adalimumab treatment.

Researchers evaluated children with arthritis, uveitis, and both.

Retrospective study results indicate that golimumab may be a new and effective choice for maintaining remission and preventing recurrence of severe, recurrent anterior uveitis in patients with HLA-B27-positive ankylosing spondylitis.